Xyosted 75 MG/0.5 ML auto-INJ 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F74LP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,305
Award facts
- Contract value 100% obligated
- $14,304.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14.3K delivery order to AmerisourceBergen Drug Corp on February 4, 2026, for the supply of Xyosted 75 mg/0.5 mL auto-injector vials. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania, with a completion date of February 5, 2026. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award IDC valued at up to $999.9M through December 2031 that serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen, as a major pharmaceutical distributor, fulfills critical medical procurement needs for federal agencies, particularly the Department of Defense and military healthcare systems. Xyosted is a testosterone replacement therapy medication commonly prescribed for treating hormone deficiencies, and this order demonstrates the company's role in supplying specialty pharmaceutical products across multiple therapeutic domains to support military treatment facilities and defense healthcare operations. The streamlined one-day delivery timeline reflects the urgent nature of pharmaceutical procurement within the federal medical supply chain and the efficiency of the established IDC vehicle for meeting government healthcare requirements.
Quick answers
Who was awarded contract SPE2DR26F74LP?
SPE2DR26F74LP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F74LP worth?
The government has obligated $14,305 on SPE2DR26F74LP.
Is contract SPE2DR26F74LP an order under another contract?
Yes. SPE2DR26F74LP is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F74LP competed?
The extent of competition for SPE2DR26F74LP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award